SCHEMBL7967069

SCHEMBL7967069

O=S(=O)(CCCN1Cc2ccccc2C1)c1ccncc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
EPHX2 P34913 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPK13 O15264 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42
MAPK14 Q16539 1/20 0.42
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
HTR7 P34969 8/20 0.41
HTR1A P08908 3/20 0.40
DRD2 P14416 2/20 0.40
HTR2C P28335 1/20 0.40
HRH1 P35367 1/20 0.40
HTR2B P41595 1/20 0.40
SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651640 0.91 HTR7 (0.54) HTR7HTR1ADRD2HRH1HTR2B
SCHEMBL7648778 0.82 KDM4E (0.53) ALDH1A1CYP1A2CYP2D6CYP2C19EPHX2
SCHEMBL2168243 0.74 ALDH1A1 (0.50) ALDH1A1CYP1A2CYP2D6CYP2C19HTR7
SCHEMBL7651469 0.74 HTR7 (0.63) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL7648765 0.71 ALDH1A1 (0.54) ALDH1A1MEN1KMT2AHTR7HTR1A
SCHEMBL7654287 0.71 HSD17B10 (0.68) ALDH1A1CYP1A2CYP2D6CYP2C19HTR7
SCHEMBL4682788 0.70 NPC1 (0.47) ALDH1A1CYP2C19KMT2AMAPK13MAPK12
SCHEMBL11530025 0.70 KMT2A (0.82) ALDH1A1EPHX2MEN1KMT2AHTR7
SCHEMBL7647665 0.70 HTR7 (0.52) HTR7HTR1ADRD2HRH1HTR2B
SCHEMBL14426918 0.69 NPC1 (0.50) ALDH1A1CYP2D6CYP2C19KMT2AKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239143-B1 TREATMENT CNS DISORDERS SUCH AS ANXIETY, DEPRESSION, SLEEP DISORDERS, AND SCHIZOPHRENIA. DUPONT PHARMACEUTICALS COMPANY 2001-05-29 US disclosed